Covariates | Crude HR 95Â % CIÂ | Adjusted HRa 95% CI | |
---|---|---|---|
Combination therapy On ART, no IPT | 1 | 1 | |
No ART, no IPT | 1.08 (0.79, 1.47) | 1.36 (0.97, 1.91) | |
No ART, treated with IPT | 1.22 (0.45, 3.28) | 1.86 (0.68, 5.10) | |
On ART, treated with IPT | 0.35 (0.16, 0.77) | 0.40 (0.18, 0.87) | |
Covariates: | Crude HR 95Â % CI | Adjusted HRa 95% CI | |
Gender (male) | 1.44 (1.12, 1.83) | 1.56 (1.18, 2.06) | |
Age (years)b | 1.01 (1.00, 1.03) | 1.01 (0.99, 1.02) | |
Baseline body weight (Kg)c | 0.98 (0.97, 0.99) | 0.99 (0.97, 1.00) | |
Baseline CD4 count (Cells/mm3)d | 1.00 (1.00, 1.01) | 1.00 (0.999, 1.001) | |
Cotrimoxazole (ever use) | 0.56 (0.43, 0.72) | 0.72 (0.51, 1.02) | |
Baseline Function functional status | Ambulatory | 1 | 1 |
Bedridden | 2.53 (1.72, 3.72) | 2.47 (1.62, 3.75) | |
Working | 0.56 (0.43, 0.73) | 0.67 (0.50, 0.89) | |
Baseline WHO HIV disease stage | Stage I | 1 | 1 |
Stage II | 1.12 (0.54, 2.31) | 1.11 (0.53, 2.30) | |
Stage III | 2.46 (1.33, 4.58) | 2.14 (1.13, 4.06) | |
Stage IV | 3.71 (1.87, 7.37) | 2.25 (1.07, 4.74) | |
Patients transferred from other hospital | 0.33 (0.17, 0.64) | 0.39 (0.18, 0.82) | |
Entry from | From the same facility | 1 | 1 |
Self-referred | 0.61 (0.20, 1.85) | 0.71 (0.23, 2.15) | |
Referred from other facilities | 0.61 (0.41, 0.87) | 0.73 (0.48, 1.10) |